-
2
-
-
0024358369
-
A rating scale for drug-induced akathisia
-
Barnes T.R. A rating scale for drug-induced akathisia. Br. J. Psychiatry 1989, 154:672-676.
-
(1989)
Br. J. Psychiatry
, vol.154
, pp. 672-676
-
-
Barnes, T.R.1
-
3
-
-
0022356785
-
Akathisia variants and tardive dyskinesia
-
Barnes T.R., Braude W.M. Akathisia variants and tardive dyskinesia. Arch. Gen. Psychiatry 1985, 42:874-878.
-
(1985)
Arch. Gen. Psychiatry
, vol.42
, pp. 874-878
-
-
Barnes, T.R.1
Braude, W.M.2
-
4
-
-
36749015768
-
Chronic restlessness with antipsychotics
-
Bratti I.M., Kane J.M., Marder S.R. Chronic restlessness with antipsychotics. Am. J. Psychiatry 2007, 164:1648-1654. 10.1176/appi.ajp.2007.07071150.
-
(2007)
Am. J. Psychiatry
, vol.164
, pp. 1648-1654
-
-
Bratti, I.M.1
Kane, J.M.2
Marder, S.R.3
-
5
-
-
39949083383
-
The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder
-
Byerly M.J., Nakonezny P.A., Rush A.J. The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder. Schizophr. Res. 2008, 100:60-69. 10.1016/j.schres.2007.12.470.
-
(2008)
Schizophr. Res.
, vol.100
, pp. 60-69
-
-
Byerly, M.J.1
Nakonezny, P.A.2
Rush, A.J.3
-
6
-
-
33644769548
-
Increased risk of extrapyramidal side-effect treatment associated with atypical antipsychotic polytherapy
-
Carnahan R.M., Lund B.C., Perry P.J., Chrischilles E.A. Increased risk of extrapyramidal side-effect treatment associated with atypical antipsychotic polytherapy. Acta Psychiatr. Scand. 2006, 113:135-141. 10.1111/j.1600-0447.2005.00589.x.
-
(2006)
Acta Psychiatr. Scand.
, vol.113
, pp. 135-141
-
-
Carnahan, R.M.1
Lund, B.C.2
Perry, P.J.3
Chrischilles, E.A.4
-
7
-
-
78650251837
-
Movement disorders induced by antipsychotic drugs: implications of the CATIE schizophrenia trial
-
Caroff S.N., Hurford I., Lybrand J., Campbell E.C. Movement disorders induced by antipsychotic drugs: implications of the CATIE schizophrenia trial. Neurol. Clin. 2011, 29:127-148. 10.1016/j.ncl.2010.10.002.
-
(2011)
Neurol. Clin.
, vol.29
, pp. 127-148
-
-
Caroff, S.N.1
Hurford, I.2
Lybrand, J.3
Campbell, E.C.4
-
8
-
-
84865408349
-
Antipsychotic polypharmacy: a comprehensive evaluation of relevant correlates of a long-standing clinical practice
-
Correll C.U., Gallego J.A. Antipsychotic polypharmacy: a comprehensive evaluation of relevant correlates of a long-standing clinical practice. Psychiatr. Clin. N. Am. 2012, 35:661-681. 10.1016/j.psc.2012.06.007.
-
(2012)
Psychiatr. Clin. N. Am.
, vol.35
, pp. 661-681
-
-
Correll, C.U.1
Gallego, J.A.2
-
9
-
-
0026753733
-
The significance of age of onset for schizophrenia
-
DeLisi L.E. The significance of age of onset for schizophrenia. Schizophr. Bull. 1992, 18:209-215.
-
(1992)
Schizophr. Bull.
, vol.18
, pp. 209-215
-
-
DeLisi, L.E.1
-
10
-
-
0034856344
-
Variables associated with disparities in treatment of patients with schizophrenia and comorbid mood and anxiety disorders
-
Dixon L., Green-Paden L., Delahanty J., Lucksted A., Postrado L., Hall J. Variables associated with disparities in treatment of patients with schizophrenia and comorbid mood and anxiety disorders. Psychiatr. Serv. 2001, 52:1216-1222.
-
(2001)
Psychiatr. Serv.
, vol.52
, pp. 1216-1222
-
-
Dixon, L.1
Green-Paden, L.2
Delahanty, J.3
Lucksted, A.4
Postrado, L.5
Hall, J.6
-
11
-
-
21844442149
-
Trends in the pharmacological treatment of patients with schizophrenia over a 12 year observation period
-
Edlinger M., Hausmann A., Kemmler G., Kurz M., Kurzthaler I., Walch T., Walpoth M., Fleischhacker W.W. Trends in the pharmacological treatment of patients with schizophrenia over a 12 year observation period. Schizophr. Res. 2005, 77:25-34. 10.1016/j.schres.2005.01.015.
-
(2005)
Schizophr. Res.
, vol.77
, pp. 25-34
-
-
Edlinger, M.1
Hausmann, A.2
Kemmler, G.3
Kurz, M.4
Kurzthaler, I.5
Walch, T.6
Walpoth, M.7
Fleischhacker, W.W.8
-
12
-
-
26844433208
-
Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
-
Faries D., Ascher-Svanum H., Zhu B., Correll C., Kane J. Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics. BMC Psychiatry 2005, 5:26. 10.1186/1471-244X-5-26.
-
(2005)
BMC Psychiatry
, vol.5
, pp. 26
-
-
Faries, D.1
Ascher-Svanum, H.2
Zhu, B.3
Correll, C.4
Kane, J.5
-
13
-
-
0003575871
-
-
New York State Psychiatric Institute, Biometrics Research, New York
-
First S.R., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition (SCID-P), Version 2 1995, New York State Psychiatric Institute, Biometrics Research, New York.
-
(1995)
Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition (SCID-P), Version 2
-
-
First, S.R.1
Gibbon, M.2
Williams, J.B.W.3
-
15
-
-
84883183997
-
Antipsychotic prescribing pathways, polypharmacy, and clozapine use in treatment of schizophrenia
-
Gören J.L., Meterko M., Williams S., Young G.J., Baker E., Chou C.-H., Kilbourne A.M., Bauer M.S. Antipsychotic prescribing pathways, polypharmacy, and clozapine use in treatment of schizophrenia. Psychiatr. Serv. 2013, 64:527-533. 10.1176/appi.ps.002022012.
-
(2013)
Psychiatr. Serv.
, vol.64
, pp. 527-533
-
-
Gören, J.L.1
Meterko, M.2
Williams, S.3
Young, G.J.4
Baker, E.5
Chou, C.-H.6
Kilbourne, A.M.7
Bauer, M.S.8
-
16
-
-
84866240639
-
Antipsychotic drugs and extrapyramidal side effects in first episode psychosis: a systematic review of head-head comparisons
-
Haddad P.M., Das A., Keyhani S., Chaudhry I.B. Antipsychotic drugs and extrapyramidal side effects in first episode psychosis: a systematic review of head-head comparisons. J. Psychopharmacol. 2012, 26:15-26. 10.1177/0269881111424929.
-
(2012)
J. Psychopharmacol.
, vol.26
, pp. 15-26
-
-
Haddad, P.M.1
Das, A.2
Keyhani, S.3
Chaudhry, I.B.4
-
17
-
-
0028297550
-
Akathisia: prevalence and associated dysphoria in an in-patient population with chronic schizophrenia
-
Halstead S.M., Barnes T.R., Speller J.C. Akathisia: prevalence and associated dysphoria in an in-patient population with chronic schizophrenia. Br. J. Psychiatry 1994, 164:177-183.
-
(1994)
Br. J. Psychiatry
, vol.164
, pp. 177-183
-
-
Halstead, S.M.1
Barnes, T.R.2
Speller, J.C.3
-
18
-
-
84872356828
-
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects
-
Hasan A., Falkai P., Wobrock T., Lieberman J., Glenthoj B., Gattaz W.F., Thibaut F., Möller H.-J., WFSBP Task force on Treatment Guidelines for Schizophrenia World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects. World J. Biol. Psychiatry 2013, 14:2-44. 10.3109/15622975.2012.739708.
-
(2013)
World J. Biol. Psychiatry
, vol.14
, pp. 2-44
-
-
Hasan, A.1
Falkai, P.2
Wobrock, T.3
Lieberman, J.4
Glenthoj, B.5
Gattaz, W.F.6
Thibaut, F.7
Möller, H.-J.8
-
19
-
-
1442264404
-
Prevalence of neuroleptic-induced movement disorders in chronic schizophrenia inpatients
-
Janno S., Holi M., Tuisku K., Wahlbeck K. Prevalence of neuroleptic-induced movement disorders in chronic schizophrenia inpatients. Am. J. Psychiatry 2004, 161:160-163.
-
(2004)
Am. J. Psychiatry
, vol.161
, pp. 160-163
-
-
Janno, S.1
Holi, M.2
Tuisku, K.3
Wahlbeck, K.4
-
20
-
-
9644279760
-
Actometry and Barnes Akathisia Rating Scale in neuroleptic-induced akathisia
-
Janno S., Holi M., Tuisku K., Wahlbeck K. Actometry and Barnes Akathisia Rating Scale in neuroleptic-induced akathisia. Eur. Neuropsychopharmacol. 2005, 15:39-41.
-
(2005)
Eur. Neuropsychopharmacol.
, vol.15
, pp. 39-41
-
-
Janno, S.1
Holi, M.2
Tuisku, K.3
Wahlbeck, K.4
-
21
-
-
77951165069
-
Evaluation of akathisia in patients with schizophrenia, schizoaffective disorder, or bipolar I disorder: a post hoc analysis of pooled data from short- and long-term aripiprazole trials
-
Kane J.M., Barnes T.R.E., Correll C.U., Sachs G., Buckley P., Eudicone J., McQuade R., Tran Q.-V., Pikalov A., Assunção-Talbott S. Evaluation of akathisia in patients with schizophrenia, schizoaffective disorder, or bipolar I disorder: a post hoc analysis of pooled data from short- and long-term aripiprazole trials. J. Psychopharmacol. 2010, 24:1019-1029. 10.1177/0269881109348157.
-
(2010)
J. Psychopharmacol.
, vol.24
, pp. 1019-1029
-
-
Kane, J.M.1
Barnes, T.R.E.2
Correll, C.U.3
Sachs, G.4
Buckley, P.5
Eudicone, J.6
McQuade, R.7
Tran, Q.-V.8
Pikalov, A.9
Assunção-Talbott, S.10
-
22
-
-
34249324437
-
Characteristics and clinical correlates of restless legs syndrome in schizophrenia
-
Kang S.-G., Lee H.-J., Jung S.W., Cho S.N., Han C., Kim Y.-K., Kim S.-H., Lee M.-S., Joe S.-H., Jung I.-K., Kim L. Characteristics and clinical correlates of restless legs syndrome in schizophrenia. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2007, 31:1078-1083. 10.1016/j.pnpbp.2007.03.011.
-
(2007)
Prog. Neuro-Psychopharmacol. Biol. Psychiatry
, vol.31
, pp. 1078-1083
-
-
Kang, S.-G.1
Lee, H.-J.2
Jung, S.W.3
Cho, S.N.4
Han, C.5
Kim, Y.-K.6
Kim, S.-H.7
Lee, M.-S.8
Joe, S.-H.9
Jung, I.-K.10
Kim, L.11
-
23
-
-
0023606101
-
The positive and negative syndrome scale (PANSS) for schizophrenia
-
Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 1987, 13:261-276.
-
(1987)
Schizophr. Bull.
, vol.13
, pp. 261-276
-
-
Kay, S.R.1
Fiszbein, A.2
Opler, L.A.3
-
24
-
-
0242326768
-
Treatment of drug-induced extrapyramidal symptoms. (a comparative study of three antiparkinson agents)
-
Kruse W. Treatment of drug-induced extrapyramidal symptoms. (a comparative study of three antiparkinson agents). Dis. Nerv. Syst. 1960, 21:79-81.
-
(1960)
Dis. Nerv. Syst.
, vol.21
, pp. 79-81
-
-
Kruse, W.1
-
25
-
-
0031808720
-
SSRI-induced extrapyramidal side-effects and akathisia: implications for treatment
-
Lane R.M. SSRI-induced extrapyramidal side-effects and akathisia: implications for treatment. J. Psychopharmacol. 1998, 12:192-214.
-
(1998)
J. Psychopharmacol.
, vol.12
, pp. 192-214
-
-
Lane, R.M.1
-
26
-
-
58049157203
-
Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis
-
Leucht S., Corves C., Arbter D., Engel R.R., Li C., Davis J.M. Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet 2009, 373:31-41. 10.1016/S0140-6736(08)61764-X.
-
(2009)
Lancet
, vol.373
, pp. 31-41
-
-
Leucht, S.1
Corves, C.2
Arbter, D.3
Engel, R.R.4
Li, C.5
Davis, J.M.6
-
27
-
-
84895767544
-
Dose equivalents for second-generation antipsychotics: the minimum effective dose method
-
Leucht S., Samara M., Heres S., Patel M.X., Woods S.W., Davis J.M. Dose equivalents for second-generation antipsychotics: the minimum effective dose method. Schizophr. Bull. 2014, 40:314-326. 10.1093/schbul/sbu001.
-
(2014)
Schizophr. Bull.
, vol.40
, pp. 314-326
-
-
Leucht, S.1
Samara, M.2
Heres, S.3
Patel, M.X.4
Woods, S.W.5
Davis, J.M.6
-
28
-
-
0038582771
-
New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis
-
Leucht S., Wahlbeck K., Hamann J., Kissling W. New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis. Lancet 2003, 361:1581-1589. 10.1016/S0140-6736(03)13306-5.
-
(2003)
Lancet
, vol.361
, pp. 1581-1589
-
-
Leucht, S.1
Wahlbeck, K.2
Hamann, J.3
Kissling, W.4
-
31
-
-
34247095585
-
On the relationship of atypical and low-dose conventional antipsychotics with akathisia in a clinical patient population
-
Markkula J., Helenius H., Lauerma H. On the relationship of atypical and low-dose conventional antipsychotics with akathisia in a clinical patient population. Nord. J. Psychiatry 2007, 61:152-157. 10.1080/08039480701226146.
-
(2007)
Nord. J. Psychiatry
, vol.61
, pp. 152-157
-
-
Markkula, J.1
Helenius, H.2
Lauerma, H.3
-
32
-
-
0033963172
-
Managing antipsychotic-induced acute and chronic akathisia
-
Miller C.H., Fleischhacker W.W. Managing antipsychotic-induced acute and chronic akathisia. Drug Saf. 2000, 22:73-81.
-
(2000)
Drug Saf.
, vol.22
, pp. 73-81
-
-
Miller, C.H.1
Fleischhacker, W.W.2
-
33
-
-
53949112680
-
Extrapyramidal side-effects of antipsychotics in a randomised trial
-
Miller D.D., Caroff S.N., Davis S.M., Rosenheck R.A., McEvoy J.P., Saltz B.L., Riggio S., Chakos M.H., Swartz M.S., Keefe R.S., Stroup T.S., Lieberman J.A., Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators Extrapyramidal side-effects of antipsychotics in a randomised trial. Br. J. Psychiatry 2008, 193:279-288. 10.1192/bjp.bp.108.050088.
-
(2008)
Br. J. Psychiatry
, vol.193
, pp. 279-288
-
-
Miller, D.D.1
Caroff, S.N.2
Davis, S.M.3
Rosenheck, R.A.4
McEvoy, J.P.5
Saltz, B.L.6
Riggio, S.7
Chakos, M.H.8
Swartz, M.S.9
Keefe, R.S.10
Stroup, T.S.11
Lieberman, J.A.12
-
34
-
-
39849090320
-
Evolution of neuroleptic-induced extrapyramidal syndromes under long-term neuroleptic treatment
-
Modestin J., Wehrli M.V., Stephan P.L., Agarwalla P. Evolution of neuroleptic-induced extrapyramidal syndromes under long-term neuroleptic treatment. Schizophr. Res. 2008, 100:97-107. 10.1016/j.schres.2007.10.018.
-
(2008)
Schizophr. Res.
, vol.100
, pp. 97-107
-
-
Modestin, J.1
Wehrli, M.V.2
Stephan, P.L.3
Agarwalla, P.4
-
35
-
-
77957132243
-
Predictors of switching antipsychotic medications in the treatment of schizophrenia
-
Nyhuis A.W., Faries D.E., Ascher-Svanum H., Stauffer V.L., Kinon B.J. Predictors of switching antipsychotic medications in the treatment of schizophrenia. BMC Psychiatry 2010, 10:75. 10.1186/1471-244X-10-75.
-
(2010)
BMC Psychiatry
, vol.10
, pp. 75
-
-
Nyhuis, A.W.1
Faries, D.E.2
Ascher-Svanum, H.3
Stauffer, V.L.4
Kinon, B.J.5
-
36
-
-
0034026407
-
Benzodiazepines in schizophrenia. Is there a trend towards long-term prescribing?
-
Paton C., Banham S., Whitmore J. Benzodiazepines in schizophrenia. Is there a trend towards long-term prescribing?. Psychiatr. Bull. 2000, 24:113-115.
-
(2000)
Psychiatr. Bull.
, vol.24
, pp. 113-115
-
-
Paton, C.1
Banham, S.2
Whitmore, J.3
-
37
-
-
44949193763
-
High-dose and combination antipsychotic prescribing in acute adult wards in the UK: the challenges posed by p.r.n. prescribing
-
Paton C., Barnes T.R.E., Cavanagh M.-R., Taylor D., Lelliott P., POMH-UK project team High-dose and combination antipsychotic prescribing in acute adult wards in the UK: the challenges posed by p.r.n. prescribing. Br. J. Psychiatry 2008, 192:435-439. 10.1192/bjp.bp.107.042895.
-
(2008)
Br. J. Psychiatry
, vol.192
, pp. 435-439
-
-
Paton, C.1
Barnes, T.R.E.2
Cavanagh, M.-R.3
Taylor, D.4
Lelliott, P.5
-
38
-
-
84883856333
-
Audit of combination and high-dose antipsychotic treatment in the community
-
Rajan L., Clarke I. Audit of combination and high-dose antipsychotic treatment in the community. Psychiatrist 2013, 37:302-307.
-
(2013)
Psychiatrist
, vol.37
, pp. 302-307
-
-
Rajan, L.1
Clarke, I.2
-
40
-
-
84555186903
-
Second-generation antipsychotic drugs and extrapyramidal side effects: a systematic review and meta-analysis of head-to-head comparisons
-
Rummel-Kluge C., Komossa K., Schwarz S., Hunger H., Schmid F., Kissling W., Davis J.M., Leucht S. Second-generation antipsychotic drugs and extrapyramidal side effects: a systematic review and meta-analysis of head-to-head comparisons. Schizophr. Bull. 2012, 38:167-177. 10.1093/schbul/sbq042.
-
(2012)
Schizophr. Bull.
, vol.38
, pp. 167-177
-
-
Rummel-Kluge, C.1
Komossa, K.2
Schwarz, S.3
Hunger, H.4
Schmid, F.5
Kissling, W.6
Davis, J.M.7
Leucht, S.8
-
41
-
-
0029045649
-
The epidemiology of drug-induced akathisia: part II. Chronic, tardive, and withdrawal akathisias
-
Sachdev P. The epidemiology of drug-induced akathisia: part II. Chronic, tardive, and withdrawal akathisias. Schizophr. Bull. 1995, 21:451-461.
-
(1995)
Schizophr. Bull.
, vol.21
, pp. 451-461
-
-
Sachdev, P.1
-
43
-
-
84941025095
-
A national network of schizophrenia expert centres: an innovative tool to bridge the research-practice gap
-
FondaMental Academic Centers of Expertise for Schizophrenia (FACE-SZ) collaborators
-
Schürhoff F., Fond G., Berna F., Bulzacka E., Vilain J., Capdevielle D., Misdrahi D., Leboyer M., Llorca P.-M. A national network of schizophrenia expert centres: an innovative tool to bridge the research-practice gap. Eur. Psychiatry 2015, 30:728-735. FondaMental Academic Centers of Expertise for Schizophrenia (FACE-SZ) collaborators.
-
(2015)
Eur. Psychiatry
, vol.30
, pp. 728-735
-
-
Schürhoff, F.1
Fond, G.2
Berna, F.3
Bulzacka, E.4
Vilain, J.5
Capdevielle, D.6
Misdrahi, D.7
Leboyer, M.8
Llorca, P.-M.9
-
45
-
-
43549111130
-
Acculturation is associated with the prevalence of tardive dyskinesia and akathisia in community-treated patients with schizophrenia
-
Sundram S., Lambert T., Piskulic D. Acculturation is associated with the prevalence of tardive dyskinesia and akathisia in community-treated patients with schizophrenia. Acta Psychiatr. Scand. 2008, 117:474-478. 10.1111/j.1600-0447.2008.01183.x.
-
(2008)
Acta Psychiatr. Scand.
, vol.117
, pp. 474-478
-
-
Sundram, S.1
Lambert, T.2
Piskulic, D.3
-
46
-
-
0018175277
-
A rating scale for mania: reliability, validity and sensitivity
-
Young R.C., Biggs J.T., Ziegler V.E., Meyer D.A. A rating scale for mania: reliability, validity and sensitivity. Br. J. Psychiatry 1978, 133:429-435.
-
(1978)
Br. J. Psychiatry
, vol.133
, pp. 429-435
-
-
Young, R.C.1
Biggs, J.T.2
Ziegler, V.E.3
Meyer, D.A.4
-
47
-
-
84924965507
-
"First do no harm." A systematic review of the prevalence and management of antipsychotic adverse effects
-
Young S.L., Taylor M., Lawrie S.M. "First do no harm." A systematic review of the prevalence and management of antipsychotic adverse effects. J. Psychopharmacol. 2015, 29:353-362. 10.1177/0269881114562090.
-
(2015)
J. Psychopharmacol.
, vol.29
, pp. 353-362
-
-
Young, S.L.1
Taylor, M.2
Lawrie, S.M.3
-
48
-
-
84878877318
-
Efficacy and safety of individual second-generation vs. first-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysis
-
Zhang J.-P., Gallego J.A., Robinson D.G., Malhotra A.K., Kane J.M., Correll C.U. Efficacy and safety of individual second-generation vs. first-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysis. Int. J. Neuropsychopharmacol. 2013, 16:1205-1218. 10.1017/S1461145712001277.
-
(2013)
Int. J. Neuropsychopharmacol.
, vol.16
, pp. 1205-1218
-
-
Zhang, J.-P.1
Gallego, J.A.2
Robinson, D.G.3
Malhotra, A.K.4
Kane, J.M.5
Correll, C.U.6
|